Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world
Indian Journal of Urology, 10/08/09
Gupta NP et al. – Lasers are superfluous in the surgical management of BPH in developing countries because of the cost, unproven long–term durability, steep learning curve, and no advantages over the gold standard management of TURP, especially with its modifications.
Related Articles
Resistive Index: A Newly Identified Predictor of Outcome of Transurethral Prostatectomy in Patients With Benign Prostatic Hyperplasia
Urology, 11/12/09
Relevance Score: 68%
Differences in Initial Benign Prostatic Hyperplasia Management Between Primary Care Physicians and Urologists
The Journal of Urology, 11/02/09
Relevance Score: 67%
Stone Formation in Prostatic Urethra After Potassium-Titanyl-Phosphate Laser Ablation of the Prostate for Benign Prostatic Hyperplasia
Journal of Endourology, 10/13/09
Relevance Score: 67%
Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia
BJU International, 11/02/09
Relevance Score: 66%
Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia
BJU International, 10/01/09
Relevance Score: 66%
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
The importance of patient selection in the treatment of distal hypospadias using modified Koff procedure
Journal of Pediatric Urology , 03/19/10
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Screening for kidney disease on World Kidney Day in Jalisco, Mexico
Journal of Nephrology, 03/19/10
Are oral antibiotics equivalent to intravenous antibiotics for the initial management of pyelonephritis in children?
Paediatrics & Child Health, 03/19/10
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
The roles of extracellular matrix proteins, apoptosis and c-kit positive cells in the pathogenesis of ureteropelvic junction obstruction
Journal of Pediatric Urology , 03/19/10
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
DNA methylation of HOXD3 as a marker of prostate cancer progression
Laboratory Investigation, 03/19/10
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Article Search
Sponsor


See Latest Articles


